United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

22 Jul 2016
Change (% chg)

$-0.15 (-2.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Jul 19 2016

BRIEF-Valeant and Progenics announce FDA approvals for relistor

* Valeant expects to commence sales of relistor tablets in U.S. in Q3 of 2016

BRIEF-Progenics Pharmaceuticals signs commercial license agreement with Selexis SA

* Under agreement, progenics will have use of Selexis CHO-M cell line and sure technology platform

BRIEF-Progenics Pharma Q1 loss per share $0.18

* Progenics pharmaceuticals announces first quarter 2016 financial and business results

BRIEF-Progenics Pharma, Valeant say FDA extended Relistor PDUFA to July 19

* Valeant and Progenics announce pdufa date extension for oral relistor

Select another date: